Symrise invests in enzymatic tech for “rare” sugar alternatives by start-up Bonumose
date:Jul 19, 2023
d diabetes and increased consumer awareness about the potential risks of excessive sugar consumption. The value of tagatose has already been validated by our existing partners/investors ASR, Hershey and now Symrise, he underscores.

We are working to encourage broad market adoption of this pure granulated tagatose as a healthier sugar option by using plant-based starch, enzymes and a patented production process, making rare monosaccharides a commercially viable/affordable alternative.

Enhan
3/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
01/15 09:09